Hereditary breast and ovarian cancer syndromes can be caused by loss-of-function germline mutations in one of two tumour-suppressor genes, BRCA1 and BRCA2 (ref. 1). Each gene product interacts with recombination/DNA repair proteins in pathways that participate in preserving intact chromosome structure. However, it is unclear to what extent such functions specifically suppress breast and ovarian cancer. Here we analyse what is known of BRCA gene function and highlight some unanswered questions in the field.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Welcsh, P. L., Owens, K. N. & King, M. C. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16, 69–74 (2000).
Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275 (1997).
Sharan, S. K. et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804–810 (1997).
Chen, J. et al. Stable interaction between the products of the BRCA1 and BRCA2 tumoursuppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317–328 (1998).
Scully, R. et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425–435 (1997).
Wu, L. C. et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet. 14, 430–440 (1996).
Keegan, K. S. et al. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev. 10 , 2423–2437 (1996).
Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162– 1166 (1999).
Deng, C. X. & Scott, F. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 19, 1059–1064 ( 2000).
Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009 –1023 (1996).
Patel, K. J. et al. Involvement of Brca2 in DNA repair. Mol. Cell 1, 347–357 (1998).
Sonoda, E. et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17, 598– 608 (1998).
Scully, R. et al. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4, 1093– 1099 (1999).
Moynahan, M. E., Chiu, J. W., Koller, B. H. & Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511–518 (1999).
Snouwaert, J. N. et al. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 18, 7900–7907 ( 1999).
Scully, R., Puget, N. & Vlasakova, K. DNA polymerase stalling, sister chromatid recombination and the BRCA genes. Oncogene (in the press).
Fornace, A. J. Jr Recombination of parent and daughter strand DNA after UV-irradiation in mammalian cells. Nature 304, 552–554 (1983).
Kowalczykowski, S. C. Initiation of genetic recombination and recombination-dependent replication. Trends Biochem. Sci. 25, 156– 165 (2000).
Cordeiro-Stone, M., Makhov, A. M., Zaritskaya, L. S. & Griffith, J. D. Analysis of DNA replication forks encountering a pyrimidine dimer in the template to the leading strand. J. Mol. Biol. 289, 1207–1218 (1999).
Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397–402 (2000).
Rotman, G. & Shiloh, Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18, 6135– 6144 (1999).
Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201–204 (2000).
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H. & Leadon, S. A. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009–1012 (1998).
Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927–939 ( 2000).
Chapman, M. S. & Verma, I. M. Transcriptional activation by BRCA1. Nature 382, 678– 679 (1996).
Monteiro, A. N., August, A. & Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl Acad. Sci. USA 93, 13595–13599 (1996).
Milner, J., Ponder, B., Hughes-Davies, L., Seltmann, M. & Kouzarides, T. Transcriptional activation functions in BRCA2. Nature 386, 772– 773 (1997).
Irminger-Finger, I., Siegel, B. D. & Leung, W. C. The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins. Biol. Chem. 380, 117–128 (1999).
Bochar, D. A. et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257–265 (2000).
Guarente, L. Diverse and dynamic functions of the Sir silencing complex. Nature Genet. 23, 281–285 ( 1999).
Paul, T. P. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886–895 (2000).
Lorick, K. L. et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA 96, 11364–11369 (1999).
Kordon, E. C. & Smith, G. H. An entire functional mammary gland may comprise the progeny from a single cell. Development 125, 1921–1930 (1998).
Tokunaga, M. et al. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950–74. J. Natl Cancer Inst. 62 , 1347–1359 (1979).
Wolden, S. L., Lamborn, K. R., Cleary, S. F., Tate, D. J. & Donaldson, S. S. Second cancers following pediatric Hodgkin's disease. J. Clin. Oncol. 16, 536 –544 (1998).
Kinzler, K. W. & Vogelstein, B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761–763 (1997).
Fishman, J., Osborne, M. P. & Telang, N. T. The role of estrogen in mammary carcinogenesis. Ann. NY Acad. Sci. 768, 91–100 (1995).
Henikoff, S. Nuclear organization and gene expression: homologous pairing and long-range interactions. Curr. Opin. Cell Biol. 9, 388–395 (1997).
Ashe, H. L., Monks, J., Wijgerde, M., Fraser, P. & Proudfoot, N. J. Intergenic transcription and transinduction of the human beta-globin locus. Genes Dev. 11, 2494–2509 (1997).
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66– 71 (1994).
Tibbetts, R. S. et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. (in the press).
Le Page, F. et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.. Cancer Res. 60, 5548–5552 ( 2000).
We thank many colleagues for stimulating discussions and for sharing data before publication. In particular, J. Feunteun, R. Tibbetts, R. Abraham, W. Bonner, M. Gellert and P. Adams.
About this article
Cite this article
Scully, R., Livingston, D. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429–432 (2000). https://doi.org/10.1038/35044000
Cancer Genetics (2021)
Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer
Current Oncology (2021)
The Cancer Journal (2021)
Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice
Scientific Reports (2021)
Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis
Journal of Assisted Reproduction and Genetics (2020)